TSH inhibits SERCA2a and the PKA/PLN pathway in rat cardiomyocytes

Jiajia Dong; Cuixia Gao; Jing Liu; Yunshan Cao; Limin Tian

doi:10.18632/oncotarget.9393

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers: Pathology:

TSH inhibits SERCA2a and the PKA/PLN pathway in rat cardiomyocytes

Jiajia Dong, Cuixia Gao, Jing Liu, Yunshan Cao and Limin Tian _

PDF | HTML | How to cite

Oncotarget. 2016; 7:39207-39215. https://doi.org/10.18632/oncotarget.9393

Metrics: PDF 2184 views | HTML 2472 views | ?

Abstract

Jiajia Dong1, Cuixia Gao2, Jing Liu1, Yunshan Cao3 and Limin Tian1

1 Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, Gansu, China

2 Department of Ultrasonic Diagnosis, Gansu Provincial Hospital, Lanzhou, Gansu, China

3 Department of Cardiology, Gansu Provincial Hospital, Lanzhou, Gansu, China

Correspondence to:

Limin Tian, email:

Keywords: TSH, SERCA2a, cardiomyocyte, PLN, PKA, Pathology Section

Received: November 10, 2015 Accepted: April 16, 2016 Published: May 16, 2016

Abstract

Elevated thyroid-stimulating hormone (TSH) levels often accompany impaired LV diastolic function and subtle systolic dysfunction in subclinical hypothyroidism (sHT). These cardiac dysfunctions are characterized by increases in mean aortic acceleration and pre-ejection/ejection time ratios. To explore the mechanism underlying these pathologies, we investigated the effects of TSH on sarcoplasmic reticulum calcium ATPase (SERCA2a) activity and expression in neonatal rat cardiomyocytes. TSH inhibited SERCA2a activity and expression by binding to TSH receptors in cardiomyocyte membranes and inhibiting the protein kinase A/phoshpolamban (PKA/PLN) signaling pathway. These results suggest that increases in serum TSH levels contribute to the development of cardiac diastolic and systolic dysfunction.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9393

Publication Alerts

Research Papers: Pathology:

TSH inhibits SERCA2a and the PKA/PLN pathway in rat cardiomyocytes

Abstract